These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7745700)

  • 1. Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.
    Paik SY; Banerjea AC; Harmison GG; Chen CJ; Schubert M
    J Virol; 1995 Jun; 69(6):3529-37. PubMed ID: 7745700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.
    Ferran MC; Lucas-Lenard JM
    J Virol; 1997 Jan; 71(1):371-7. PubMed ID: 8985359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.
    Lyles DS; McKenzie MO; Ahmed M; Woolwine SC
    Virology; 1996 Nov; 225(1):172-80. PubMed ID: 8918544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.
    Meier E; Harmison GG; Schubert M
    J Virol; 1987 Oct; 61(10):3133-42. PubMed ID: 3041035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly.
    Black BL; Rhodes RB; McKenzie M; Lyles DS
    J Virol; 1993 Aug; 67(8):4814-21. PubMed ID: 8392615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation.
    Kaptur PE; McKenzie MO; Wertz GW; Lyles DS
    Virology; 1995 Feb; 206(2):894-903. PubMed ID: 7856102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies of the RNA synthesis phenotype selected during persistent infection with vesicular stomatitis virus.
    Frey TK; Youngner JS
    Virology; 1984 Jul; 136(1):211-20. PubMed ID: 6204450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.
    Lefkowitz EJ; Pattnaik AK; Ball LA
    Virology; 1990 Oct; 178(2):373-83. PubMed ID: 2171187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-binding domains and cytopathogenesis of the matrix protein of vesicular stomatitis virus.
    Ye Z; Sun W; Suryanarayana K; Justice P; Robinson D; Wagner RR
    J Virol; 1994 Nov; 68(11):7386-96. PubMed ID: 7933122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression.
    Kopecky SA; Lyles DS
    J Virol; 2003 Apr; 77(8):4658-69. PubMed ID: 12663772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.
    Blondel D; Harmison GG; Schubert M
    J Virol; 1990 Apr; 64(4):1716-25. PubMed ID: 2157054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.
    Kopecky SA; Willingham MC; Lyles DS
    J Virol; 2001 Dec; 75(24):12169-81. PubMed ID: 11711608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominance of temperature-sensitive phenotypes. II. Vesicular stomatitis virus mutants from a persistent infection interfere with shut-off of host protein synthesis by wild-type virus.
    Jordan JA; Youngner JS
    Virology; 1987 Jun; 158(2):407-13. PubMed ID: 3035789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation.
    Grdzelishvili VZ; Smallwood S; Tower D; Hall RL; Hunt DM; Moyer SA
    J Virol; 2005 Jun; 79(12):7327-37. PubMed ID: 15919887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of RNA by mutants of vesicular stomatitis virus (Indiana serotype) and the ability of wild-type VSV New Jersey to complement the VSV Indiana ts G I-114 transcription defect.
    Repik P; Flamand A; Bishop DH
    J Virol; 1976 Oct; 20(1):157-69. PubMed ID: 185410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominance of temperature-sensitive phenotypes. I. Studies of the mechanism of inhibition of the growth of wild-type vesicular stomatitis virus.
    Youngner JS; Frielle DW; Whitaker-Dowling P
    Virology; 1986 Nov; 155(1):225-35. PubMed ID: 3022472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
    Kim GN; Kang CY
    Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
    Johnson JE; Schnell MJ; Buonocore L; Rose JK
    J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function.
    Lyles DS; McKenzie MO
    Virology; 1997 Mar; 229(1):77-89. PubMed ID: 9123880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.